The impact of surgery for metastatic pancreatic neuroendocrine tumor: a contemporary evaluation matching for chromogranin a level.

Abstract

BACKGROUND:

Studies supporting surgical management of metastatic pancreatic neuroendocrine tumor (PNET) are limited by selection bias. Chromogranin A (CgA) has been used as a biomarker for PNET and may reflect disease burden or biology. This study aimed to correlate CgA level with overall survival and to use it to match patients selected for different treatment approaches in an analysis of the impact of surgical management.

METHODS:

1478 patients diagnosed with PNET in the National Cancer Database (2004-2014) were retrospectively identified, and logistic regression analyses were used to evaluate associations between the presence of metastatic disease and CgA level. After matching patients by CgA level and other factors predictive of surgical management, Kaplan-Meier survival analysis was performed.

RESULTS:

Median CgA level was significantly higher in metastatic versus localized PNET(169 ng/mL versus 66 ng/mL, p < 0.001). On multivariate logistic regression, CgA level was predictive of metastatic disease(OR 1.002, p < 0.001) and survival in metastatic and non-metastatic patients. After matching for CgA level, surgery was associated with improved overall survival.

DISCUSSION:

CgA level is predictive of the presence of distant metastatic disease and overall survival in PNET. When matched by CgA and other predictors of treatment approach, patients with metastatic PNET undergoing surgery have improved survival.

• Authors: Seth J Concors, Andrew J Sinnamon, Brett L Ecker, David C Metz, Charles M Vollmer, Douglas L Fraker, Robert E Roses
• Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association (HPB (Oxford)) Vol. 22 Issue 1 Pg. 83-90 (01 2020) ISSN: 1477-2574 [Electronic] England
• PMID: 31239188 (Publication Type: Journal Article)
• Copyright: Copyright © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Chemical References

• Biomarkers
• Chromogranin A

Topics

• Aged
• Biomarkers (blood)
• Chromogranin A (blood)
• Female
• Humans
• Kaplan-Meier Estimate
• Logistic Models
• Male
• Middle Aged
• Neoplasm Staging
• Neuroendocrine Tumors (blood, secondary, surgery)
• Pancreatic Neoplasms (blood, pathology, surgery)
• Predictive Value of Tests
• Retrospective Studies
• Treatment Outcome